Australian company Noxopharm (ASX:NOX) has reported positive end-of-study data from its DARRT-1 Phase 1b trial of Veyonda. …
Latest Video
New Stories
-
Intensifying global battle for medical supplies
April 6, 2020 - - Latest News -
Shipment delay causing concern over India lockdown
April 6, 2020 - - Latest News -
Government invests $220m in biosecurity facility
April 6, 2020 - - Latest News -
Industry welcomes ACCC interim authorisation
April 6, 2020 - - Latest News -
Australian industry joins the COVID-19 response
April 6, 2020 - - Latest News -
ACCC confirms limited authorisation for manufacturers during COVID-19
April 4, 2020 - - Latest News -
COVID-19 hits medical research as MRFF defers grants
April 4, 2020 - - Latest News